Mitochondrial Function in Patients with Severe Liver Disease
common.study.values.description
“Mitochondrial Function in Patients With Severe Liver Disease”
The researchers will recruit patients with liver disease at Parkland Hospital. Patients will fast overnight, and the next morning will receive an oral mixture of [U-13C3]glycerol (25 mg/kg) plus unlabeled glycerol (25 mg/kg). The total dose of glycerol will be 50 mg/kg in 100 milliliters of water. The taste is slightly sweet. Blood will be drawn at 60 min and 120 min after the ingestion. Blood glucose will be isolated and analyzed by NMR. The presence of [5,6-13C2]- and [4,5-13C2]glucose indicates preserved mitochondrial function. The researchers anticipate that patients with severe liver disease will show a decrease in mitochondrial function and will inform biosynthetic function of liver mitochondria. After the first 6 successful exams (see power analysis, below), healthy volunteers (age-, gender-, and race-matched) will be studied at the AIRC and subject to the same protocol.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods


Orally administered labeled glycerol
Oral administration of labeled glycerol
participant.views.study.view.additional
participant.views.study.view.scientific-title
Mitochondrial Function in Patients With Severe Liver Disease
common.study.values.clinical-trial-id
NCT02457702
participant.views.study.view.id
nelM7a